Cargando…
Assessment of Doripenem, Meropenem, and Imipenem against Respiratory Isolates of Pseudomonas aeroginosa in a Tertiary Care Hospital of North India
OBJECTIVE: Pseudomonas aeruginosa is one of the leading pathogen causing healthcare-associated infections, particularly in immunocompromised and critically ill patients. The development of carbapenem resistance in P. aeruginosa infections is worrisome. Data specifically comparing the susceptibility...
Autores principales: | Negi, Arti, Anand, Mridu, Singh, Avinash, Kumar, Awadhesh, Sahu, Chinmoy, Prasad, Kashi Nath |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5672677/ https://www.ncbi.nlm.nih.gov/pubmed/29142383 http://dx.doi.org/10.4103/ijccm.IJCCM_341_17 |
Ejemplares similares
-
In vitro antibacterial activity of rifampicin in combination with imipenem, meropenem and doripenem against multidrug-resistant clinical isolates of Pseudomonas aeruginosa
por: Hu, Yi-Fan, et al.
Publicado: (2016) -
Vancomycin-Resistant Pseudomonas Aeroginosa in the Cases of Trauma
por: Ahmadi, Koorosh, et al.
Publicado: (2016) -
Morphological and Bactericidal Effects of Amikacin, Meropenem and Imipenem on Pseudomonas aeruginosa
por: Moghoofei, Mohsen, et al.
Publicado: (2015) -
The Era of Device Colonizers: Chryseobacterium indologenes Infections from a Tertiary Care Center in North India
por: Jain, Vidhi, et al.
Publicado: (2018) -
Mutant Prevention Concentrations of Imipenem and Meropenem against Pseudomonas aeruginosa and Acinetobacter baumannii
por: Dahdouh, E., et al.
Publicado: (2014)